BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv7.32.0//EN
X-ORIGINAL-URL:https://oligotherapeutics.org/
X-WR-CALNAME:Oligonucleotide Therapeutics Society
X-WR-CALDESC:Oligonucleotide Therapeutics Society
X-WR-TIMEZONE:UTC
BEGIN:VTIMEZONE
TZID:UTC
X-LIC-LOCATION:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20260514T133708
END:STANDARD
END:VTIMEZONE
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
UID:MEC-20314c01c1fdfe3bebe0a5c7c7bd1721@oligotherapeutics.org
DTSTART;TZID=UTC:20240627T000000
DTEND;TZID=UTC:20240628T000000
DTSTAMP:20240516T172040Z
CREATED:20240516
LAST-MODIFIED:20240516
PRIORITY:5
SEQUENCE:0
TRANSP:OPAQUE
SUMMARY:UK Platform for Nucleic Acid Therapies (UPNAT) Inaugural Symposium
DESCRIPTION:\nThe Medical Research Council (MRC) and National Institute for Health and Care Research (NIHR) have committed ca. £14m to establish a UK Rare Diseases Research Platform, comprising 11 “nodes” based in universities across the UK. Each node is working on a research project that is either focused on one disease area or across multiple rare diseases, and whilst the nodes are based at universities, we are also working with charities, industry and other universities to ensure that we are reaching the right people for our research.\nWe are the UPNAT Node (“Establishing a UK Platform of Nucleic Acid Therapy for Rare Disease”).\nThe aim of the UPNAT Node is to bring together relevant stakeholders to establish a national network promoting knowledge-exchanging and innovation in pre-clinical development and rapid clinical translation of Nucleic Acid Therapies for rare disease.\nThe agenda will include sessions on:\nReal-world experience from patients & clinicians\n-Piotr Kosla (parent, PACS2 Research Foundation, and Simons Searchlight Community Advisory Committee member)\n-Francesco Muntoni (Chair of Paediatric Neurology, UCL)\nTarget selection\nStephan Sanders (Professor of Neurogenetics, Oxford)\nAna Lisa Taylor Tavares (Clinical Lead for rare disease research, Genomics England)\nClinical trials and regulatory path\nSarah Tabrizi (Professor of Clinical Neurology, UCL)\nDaniel O’Connor (Director of Regulatory and Early Access Policy, Association of the British Pharmaceutical Industry)\nWilleke van Roon-Mom (Professor of Human Genetics, Leiden University)\n+Panel discussion, chaired by Paul Gissen (Clinical Professor of Paediatric Metabolic Medicine, UCL Great Ormond Street Institute of Child Health)\n
URL:https://oligotherapeutics.org/calendar-events/uk-platform-for-nucleic-acid-therapies-upnat-inaugural-symposium/
ORGANIZER;CN=UK Platform for Nucleic Acid Therapies for Rare Disease (UpNAT Node):MAILTO:UPNAT@ucl.ac.uk
CATEGORIES:Local Delivery Event
LOCATION:London, WC1H 1EH, UK
ATTACH;FMTTYPE=image/webp:https://oligotherapeutics.org/wp-content/uploads/2024/04/OTS-Local-Delivery-Banner-res.webp
END:VEVENT
END:VCALENDAR